Syngenta

Last updated January 31, 2026

Innovation Areas

1,941

Inventors

Collaborations

Polymorphic and cocrystal phase engineering: SyngentaRecent Research Landscape

Unstable active ingredient phases lead to inconsistent bioavailability and shelf-life degradation. Precise control of the monohydrate crystalline lattice ensures thermodynamic stability and predictable dissolution rates.

What technical problems is Syngenta addressing in Polymorphic and cocrystal phase engineering?

Poor aqueous solubility

(5)evidences

Unpredictable phase transitions and hydration states lead to inconsistent bioavailability and shelf-life. Controlling polymorphism prevents unintended structural degradation in complex formulations.